Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-risk early-stage lung adenocarcinoma patients are identified by an immune-related circadian clock gene signature. | J Thorac Dis | 2022 | 36389316 | PubTator, text mining | PubMed |
| Direct reprogramming of cardiomyocytes into cardiac Purkinje-like cells. | iScience | 2022 | 36388958 | PubTator, text mining | PubMed |
| Relationship between endogenous testosterone and prostate carcinoma. | J Family Med Prim Care | 2022 | 36387691 | PubTator, text mining | PubMed |
| The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression. | Elife | 2022 | 36383412 | PubTator, text mining | PubMed |
| Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2. | Molecules | 2022 | 36364238 | PubTator, text mining | PubMed |
| Generation of Lens Progenitor Cells and Lentoid Bodies from Pluripotent Stem Cells: Novel Tools for Human Lens Development and Ocular Disease Etiology. | Cells | 2022 | 36359912 | PubTator, text mining | PubMed |
| Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer. | Biomolecules | 2022 | 36358940 | PubTator, text mining | PubMed |
| CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers. | Cancers (Basel) | 2022 | 36358827 | PubTator, text mining | PubMed |
| MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation. | Biomark Insights | 2022 | 36341281 | PubTator, text mining | PubMed |
| The genetics of myelodysplastic syndromes and the opportunities for tailored treatments. | Front Oncol | 2022 | 36338673 | PubTator, text mining | PubMed |
| Identification of transcription factors dictating blood cell development using a bidirectional transcription network-based computational framework. | Sci Rep | 2022 | 36333382 | PubTator, text mining | PubMed |
| Prolylcarboxypeptidase promotes IGF1R/HER3 signaling and is a potential target to improve endocrine therapy response in estrogen receptor positive breast cancer. | Cancer Biol Ther | 2022 | 36332175 | PubTator, text mining | PubMed |
| IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers. | Clin Pathol | 2022 | 36313587 | PubTator, text mining | PubMed |
| BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma. | Cancer Discov | 2022 | 36305736 | PubTator, text mining | PubMed |
| Chitosan degradation products promote healing of burn wounds of rat skin. | Front Bioeng Biotechnol | 2022 | 36304900 | PubTator, text mining | PubMed |
| HIF-3α-Induced miR-630 Expression Promotes Cancer Hallmarks in Cervical Cancer Cells by Forming a Positive Feedback Loop. | J Immunol Res | 2022 | 36277475 | PubTator, text mining | PubMed |
| The genetics of occupational asthma development among workers exposed to diisocyanates: A systematic literature review with meta-analysis. | Front Genet | 2022 | 36276967 | PubTator, text mining | PubMed |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. | Front Immunol | 2022 | 36275733 | PubTator, text mining | PubMed |
| Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. | Mater Today Bio | 2022 | 36267139 | PubTator, text mining | PubMed |
| Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches. | PLoS One | 2022 | 36264868 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=18